[Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma]
- PMID: 15975276
[Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma]
Abstract
Objectives: To study the relationship between the expression level of DLC-1 mRNA (located in 8p) and the invasion/metastasis of human hepatocellular carcinoma (HCC).
Methods: Fifty-one surgical specimens of human HCC were divided into high-invasive and low invasive groups according to their clinicopathological features. DLC-1 mRNA expression was studied in the 51 HCC specimens as well as 5 different metastasis potential cell lines using real-time quantitative PCR (RQ-PCR).
Results: The expression level of DLC-1 mRNA in HCC specimens with high invasiveness was significantly lower than that with low invasiveness (P < 0.05). The expression levels of DLC-1 mRNA were significantly different between non-metastatic (Hep3B and HepG2) and metastatic (MHCC97-H, MHCC97-L and HCCLM3) cell lines (P < 0.05). From MHCC97-L to HCCLM3, with an increase of invasiveness and metastatic potentials, the expression level of DLC-1 decreased correspondingly, and its expression level in HCCLM3 was significantly lower than that in MHCC97-L (P < 0.01).
Conclusion: The expression of DLC-1 mRNA may play an important role in inhibiting the invasiveness and metastasis of HCC.
Similar articles
-
[Expression of CXCR3 in hepatocellular carcinoma].Ai Zheng. 2006 Oct;25(10):1232-7. Ai Zheng. 2006. PMID: 17059766 Chinese.
-
[The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].Zhonghua Gan Zang Bing Za Zhi. 2006 Jul;14(7):489-94. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16867268 Chinese.
-
[Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials].Zhonghua Gan Zang Bing Za Zhi. 2007 Apr;15(4):261-5. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17456312 Chinese.
-
The Role of Tumor Suppressor DLC-1: Far From Clear.Anticancer Agents Med Chem. 2017;17(7):896-901. doi: 10.2174/1871520616666160907142754. Anticancer Agents Med Chem. 2017. PMID: 27604574 Review.
-
Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.Int J Biochem Cell Biol. 2008;40(5):843-7. doi: 10.1016/j.biocel.2007.04.008. Epub 2007 Apr 20. Int J Biochem Cell Biol. 2008. PMID: 17521951 Free PMC article. Review.
Cited by
-
The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.PLoS One. 2012;7(7):e40302. doi: 10.1371/journal.pone.0040302. Epub 2012 Jul 5. PLoS One. 2012. PMID: 22792269 Free PMC article.
-
Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.Mol Diagn Ther. 2014 Jun;18(3):293-302. doi: 10.1007/s40291-014-0086-3. Mol Diagn Ther. 2014. PMID: 24519699 Free PMC article. Review.
-
Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.PLoS One. 2008 Jul 23;3(7):e2779. doi: 10.1371/journal.pone.0002779. PLoS One. 2008. PMID: 18648664 Free PMC article.
-
DLC-1:a Rho GTPase-activating protein and tumour suppressor.J Cell Mol Med. 2007 Sep-Oct;11(5):1185-207. doi: 10.1111/j.1582-4934.2007.00098.x. J Cell Mol Med. 2007. PMID: 17979893 Free PMC article. Review.
-
Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.J Clin Invest. 2010 Jan;120(1):223-41. doi: 10.1172/JCI38012. Epub 2009 Dec 14. J Clin Invest. 2010. PMID: 20038795 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials